Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
Imaging in multiple sclerosis and related disorders.
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Systemic Injection of Low-Dose Lipopolysaccharide Fails to Break down the Blood-Brain Barrier or Activate the TLR4-MyD88 Pathway in Neonatal Rat Brain.
Pathogenesis of immune-mediated neuropathies.
Obturator neurolysis using 65% alcohol for adductor muscle spasticity.
[Good practice in prophylactic care: prophylactic care and professional activation of employees with multiple sclerosis].
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Stem cell therapy independent of stemness.
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica.
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Regulatory dendritic cell therapy: From rodents to clinical application.
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.
Multi-Sectional Views Textural Based SVM for MS Lesion Segmentation in Multi-Channels MRIs.
Vitamin D supplementation, moderate sun exposure, and control of immune Diseases.
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
Corticosteroids for treating optic neuritis.
Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study.
Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Pages
« first
‹ previous
…
431
432
433
434
435
436
437
438
439
…
next ›
last »